Ionis Pharmaceuticals IONS Deferred Tax Assets Liabilities Net Before Valuation Allowance
Deferred Tax Assets Liabilities Net Before Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's deferred tax assets liabilities net before valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's deferred tax assets liabilities net before valuation allowance?
- Ionis Pharmaceuticals (IONS) reported deferred tax assets liabilities net before valuation allowance of $1.24B in Q4 2025.
- What does deferred tax assets liabilities net before valuation allowance mean?
- The net total of all deferred tax items before adjusting for the likelihood of actually using them.
- How do you interpret deferred tax assets liabilities net before valuation allowance?
- Provides a baseline for understanding the total magnitude of temporary tax differences.
- How does deferred tax assets liabilities net before valuation allowance compare across companies?
- Standard accounting disclosure for tax reconciliation.